Nanoparticle delivery vehicle
A nanoparticle delivery vehicle, comprising a nanoparticle, an active agent and a nuclear localization signal and methods of modulating gene expression and protein expression employing the nanoparticle delivery vehicle. A representative method includes providing a nanoparticle delivery vehicle comprising a nanoparticle having a diameter of about 30 nm or less, an active agent and a nuclear localization signal; and contacting a target cell with the nanoparticle delivery vehicle, whereby an active agent is delivered to the nucleus of a target cell. Another representative method includes providing a nanoparticle delivery vehicle comprising a nanoparticle having a diameter greater than or equal to about 30 nm, an active agent and a nuclear localization signal; and contacting a target cell with the nanoparticle delivery vehicle, whereby an active agent is delivered to the cytoplasm of a cell.
1. A nanoparticle delivery vehicle for contacting a target cell and crossing a cellular membrane and a nuclear membrane of a target cell, the nanoparticle delivery vehicle comprising:
(a) a nanoparticle, wherein the nanoparticle comprises a material selected from the group consisting of cadmium selenide, titanium, titanium dioxide, tin, tin oxide, silicon, silicon dioxide iron, iron III oxide, silver, nickel, gold, copper, aluminum, steel, cobalt-chrome alloy, titanium alloy, brushite, tricalcium phosphate, alumina, silica, zirconia, diamond, polystyrene, silicone rubber, polycarbonate, polyurethanes, polypropylenes, polymethylmethaacrylate, polyvinyl chloride, polyesters, polyethers, and polyethylene;
(b) an active agent;
(c) a nuclear localization signal; and
(d) one or more extracellular targeting agents, wherein the one or more extracellular targeting agents is recognized and bound by one or more receptors on a surface of a target cell.
2. The nanoparticle delivery vehicle of claim 1 , wherein the nanoparticle is biodegradable.
3. The nanoparticle delivery vehicle of claim 1 , wherein the nanoparticle ranges from about 1 nm to about 1,000 nm in diameter.
4. The nanoparticle delivery vehicle of claim 1 , wherein the nanoparticle is about 30 nm or less in diameter.
5. The nanoparticle delivery vehicle of claim 1 , wherein the active agent is selected from the group consisting of oligomers of double stranded nucleic acids, single stranded nucleic acids, chemically modified nucleic acids, peptide nucleic acids, proteins and small molecules.
6. The nanoparticle delivery vehicle of claim 1 , further comprising a tether sequence attached to, and disposed between, the active agent and the nanoparticle.
7. The nanoparticle delivery vehicle of claim 1 , wherein the nanoparticle delivery vehicle is disposed in a pharmaceutically acceptable diluent.
8. The nanoparticle delivery vehicle of claim 1 , further comprising a detectable moiety.
9. The nanoparticle delivery vehicle of claim 8 , wherein the detectable moiety is a fluorescent compound.
10. The nanoparticle delivery vehicle of claim 1 , wherein each sequence is independently associated with the nanoparticle.
11. The nanoparticle delivery vehicle of claim 1 , wherein the extracellular targeting agent is an RME motif.
12. The nanoparticle delivery vehicle of claim 1 , wherein the extracellular targeting agent is selected from the group consisting of diptheria toxin, pseudomonas toxin, cholera toxin, ricin, concanavalin A, Rous sarcoma virus, Semliki forest virus, vesicular stomatitis virus, adenovirus, transferrin, low density lipoprotein, transcobalamin, yolk proteins, IgE, polymeric IgA, maternal IgG, insulin, epidermal growth factor, growth hormone, thyroid stimulating hormone, nerve growth factor calcitonin, glucagon, prolactin, luteinizing hormone, thyroid hormone, platelet derived growth factor, interferon, nuclear localization signal and catecholamines.
13. The nanoparticle delivery vehicle of claim 1 , wherein the extracellular targeting agent comprises a fragment of a molecule selected from the group consisting of diptheria toxin, pseudomonas toxin, cholera toxin, ricin, concanavalin A, Rous sarcoma virus, Semliki forest virus, vesicular stomatitis virus, adenovirus, transferrin, low density lipoprotein, transcobalamin, yolk proteins, IgE, polymeric IgA, maternal IgG, insulin, epidermal growth factor, growth hormone thyroid stimulating hormone, nerve growth factor, calcitonin, glucagon, prolactin, luteinizing hormone, thyroid hormone, platelet derived growth factor, interferon and catecholamines.
14. The nanoparticle delivery vehicle of claim 1 , further comprising two or more different active agents.
15. The nanoparticle delivery vehicle of claim 1 , further comprising a biocompatibility-enhancing agent.
16. The nanoparticle delivery vehicle of claim 1 , further comprising a protective coating covering at least part of the delivery vehicle.
17. The nanoparticle delivery vehicle of claim 16 , further comprising a protective coating covering the entire delivery vehicle.
18. The nanoparticle delivery vehicle of claim 16 , wherein the protective coating comprises a polymer.
19. The nanoparticle delivery vehicle of claim 16 , wherein the protective coating comprises a biological material.
20. The nanoparticle delivery vehicle of claim 16 , wherein the biological material is a protein, lipid, carbohydrate, or combination thereof.
21. A nanoparticle delivery vehicle for contacting a target cell and crossing a cellular membrane and a nuclear membrane of a target cell, the nanoparticle delivery vehicle comprising:
(a) a nanoparticle, wherein the nanoparticle comprises a material selected from the group consisting of cadmium selenide, titanium, titanium dioxide, tin, tin oxide, silicon, silicon dioxide, iron, iron III oxide, silver, nickel, gold, copper, aluminum, steel, cobalt-chrome alloy, titanium alloy. brushite, tricalcium phosphate, alumina, silica, zirconia, diamond, polystyrene, silicone rubber, polycarbonate, polyurethanes, polypropylenes, polymethylmethaacrylate, polyvinyl chloride, polyesters, polyethers, and polyethylene;
(b) an active agent;
(c) a nuclear localization signal; and
(d) one or more extracellular targeting agents, wherein the one or more extracellular targeting agents is recognized and bound by one or more receptors on a surface of a target cell;
wherein the nuclear localization signal or one of the one or more extracellular targeting agents is selected from the group consisting of SEQ ID NOs: 4-6, and combinations thereof.
22. A nanoparticle delivery vehicle for contacting a target cell and crossing a cellular membrane and a nuclear membrane of a target cell, the nanoparticle delivery vehicle comprising:
(a) a nanoparticle, wherein the nanoparticle comprises a material selected from the group consisting of cadmium selenide, titanium, titanium dioxide, tin, tin oxide, silicon, silicon dioxide, iron, iron III oxide, silver, nickel, gold, copper, aluminum, steel, cobalt-chrome alloy, titanium alloy, brushite, tricalcium phosphate, alumina, silica, zirconia, diamond, polystyrene, silicone rubber, polycarbonate, polyurethanes, polypropylenes, polymethylmethaacrylate, polyvinyl chloride, polyesters, polyethers, and polyethylene;
(b) an active agent;
(c) a nuclear localization signal; and
(d) one or more extracellular targeting agents, wherein the one or more extracellular targeting agents is recognized and bound by one or more receptors on a surface of a target cell;
wherein the nuclear localization signal comprises SEQ ID NO: 4 and one of the one or more extracellular targeting agents comprises SEQ ID NO: 5.
23. The nanoparticle delivery vehicle of claim 22 , wherein the target cell is a human hepatocarcinoma cell.
24. A nanoparticle delivery vehicle for contacting a target cell and crossing a cellular membrane and a nuclear membrane of a target cell, the nanoparticle delivery vehicle comprising:
(a) a nanoparticle, wherein the nanoparticle comprises a material selected from the group consisting of cadmium selenide, titanium, titanium dioxide, tin, tin oxide, silicon, silicon dioxide, iron, iron III oxide, silver, nickel, gold, copper, aluminum, steel, cobalt-chrome alloy, titanium alloy, brushite, tricalcium phosphate, alumina, silica, zirconia, diamond, polystyrene, silicone rubber, polycarbonate, polyurethanes. polypropylenes, polymethylmethaacrylate, polyvinyl chloride, polyesters, polyethers, and polyethylene;
(b) an active agent;
(c) a nuclear localization signal; and
(d) one or more extracellular targeting agents, wherein the one or more extracellular targeting agents is recognized and bound by one or more receptors on a surface of a target cell;
wherein the nuclear localization signal and one of the one or more extracellular targeting agents together comprise SEQ ID NO: 6.
25. The nanoparticle delivery vehicle of claim 24 , wherein the target cell is a human hepatocarcinoma cell.
26. A nanoparticle delivery vehicle for contacting a target cell and crossing a cellular membrane and a nuclear membrane of a target cell, the nanoparticle delivery vehicle comprising:
(a) a nanoparticle;
(b) an active agent;
(c) a nuclear localization signal; and
(d) one or more extracellular targeting agents, wherein the one or more extracellular targeting agents is recognized and bound by one or more receptors on a surface of a target cell;
wherein the nuclear localization signal or one of the one or more extracellular targeting agents is selected from the group consisting of SEQ ID NOs: 4-6, and combinations thereof.